BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 31589177)

  • 1. Vitamin D and nonalcoholic fatty liver disease.
    Zhang Z; Thorne JL; Moore JB
    Curr Opin Clin Nutr Metab Care; 2019 Nov; 22(6):449-458. PubMed ID: 31589177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update.
    Barchetta I; Cimini FA; Cavallo MG
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33126575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D Level and Vitamin D Receptor Genetic Variation Were Involved in the Risk of Non-Alcoholic Fatty Liver Disease: A Case-Control Study.
    Zhang R; Wang M; Wang M; Zhang L; Ding Y; Tang Z; Fu Z; Fan H; Zhang W; Wang J
    Front Endocrinol (Lausanne); 2021; 12():648844. PubMed ID: 34421816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Polymorphisms and Biological Effects of Vitamin D Receptor on Nonalcoholic Fatty Liver Disease Development and Progression.
    Tourkochristou E; Mouzaki A; Triantos C
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of vitamin D supplementation on liver fibrogenic factors in non-alcoholic fatty liver patients with steatohepatitis: study protocol for a randomized clinical trial.
    Ebrahimpour-Koujan S; Sohrabpour AA; Foroughi F; Alvandi E; Esmaillzadeh A
    Trials; 2019 Mar; 20(1):153. PubMed ID: 30832722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D and Nonalcoholic Fatty Liver Disease: Bi-directional Mendelian Randomization Analysis.
    Wang N; Chen C; Zhao L; Chen Y; Han B; Xia F; Cheng J; Li Q; Lu Y
    EBioMedicine; 2018 Feb; 28():187-193. PubMed ID: 29339098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of vitamin D levels and vitamin D-related gene polymorphisms with liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease.
    Arai T; Atsukawa M; Tsubota A; Koeda M; Yoshida Y; Okubo T; Nakagawa A; Itokawa N; Kondo C; Nakatsuka K; Masu T; Kato K; Shimada N; Hatori T; Emoto N; Kage M; Iwakiri K
    Dig Liver Dis; 2019 Jul; 51(7):1036-1042. PubMed ID: 30683615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A narrative review on effects of vitamin D on main risk factors and severity of Non-Alcoholic Fatty Liver Disease.
    Sangouni AA; Ghavamzadeh S; Jamalzehi A
    Diabetes Metab Syndr; 2019; 13(3):2260-2265. PubMed ID: 31235166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Vitamin D Levels and Nonalcoholic Fatty Liver Disease: Potential Confounding Variables.
    Pacifico L; Osborn JF; Bonci E; Pierimarchi P; Chiesa C
    Mini Rev Med Chem; 2019; 19(4):310-332. PubMed ID: 30360708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D and histologic severity of nonalcoholic fatty liver disease: A systematic review and meta-analysis.
    Jaruvongvanich V; Ahuja W; Sanguankeo A; Wijarnpreecha K; Upala S
    Dig Liver Dis; 2017 Jun; 49(6):618-622. PubMed ID: 28274829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D signaling maintains intestinal innate immunity and gut microbiota: potential intervention for metabolic syndrome and NAFLD.
    Zeng Y; Luo M; Pan L; Chen Y; Guo S; Luo D; Zhu L; Liu Y; Pan L; Xu S; Zhang R; Zhang C; Wu P; Ge L; Noureddin M; Pandol SJ; Han YP
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G542-G553. PubMed ID: 31984787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between vitamin D status and nonalcoholic fatty liver disease in children.
    Hourigan SK; Abrams S; Yates K; Pfeifer K; Torbenson M; Murray K; Roth CL; Kowdley K; Scheimann AO;
    J Pediatr Gastroenterol Nutr; 2015 Mar; 60(3):396-404. PubMed ID: 25710716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes.
    Cipponeri E; Vitturi N; Mariano V; Boscari F; Galasso S; Crepaldi C; Fadini GP; Vigili de Kreutzenberg S; Marescotti MC; Iori E; Cavallin F; Sartori L; Baritussio A; Avogaro A; Bruttomesso D
    J Endocrinol Invest; 2019 Sep; 42(9):1099-1107. PubMed ID: 30847862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Barchetta I; Del Ben M; Angelico F; Di Martino M; Fraioli A; La Torre G; Saulle R; Perri L; Morini S; Tiberti C; Bertoccini L; Cimini FA; Panimolle F; Catalano C; Baroni MG; Cavallo MG
    BMC Med; 2016 Jun; 14():92. PubMed ID: 27353492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low vitamin D levels and non-alcoholic fatty liver disease, evidence for their independent association in men in East China: a cross-sectional study (Survey on Prevalence in East China for Metabolic Diseases and Risk Factors (SPECT-China)).
    Zhai HL; Wang NJ; Han B; Li Q; Chen Y; Zhu CF; Chen YC; Xia FZ; Cang Z; Zhu CX; Lu M; Lu YL
    Br J Nutr; 2016 Apr; 115(8):1352-9. PubMed ID: 26888280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future.
    Barchetta I; Cimini FA; Cavallo MG
    Nutrients; 2017 Sep; 9(9):. PubMed ID: 28906453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of vitamin D supplement in children with nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis.
    Liu J; Wang T; Chen J; Zhang Y; Yin X; Fan X; Chen Q
    Medicine (Baltimore); 2020 Jul; 99(31):e20960. PubMed ID: 32756082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D/vitamin D receptor pathway in non-alcoholic fatty liver disease.
    Liu J; Song Y; Wang Y; Hong H
    Expert Opin Ther Targets; 2023; 27(11):1145-1157. PubMed ID: 37861098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D supplementation and non-alcoholic fatty liver disease: A critical and systematic review of clinical trials.
    Sharifi N; Amani R
    Crit Rev Food Sci Nutr; 2019; 59(4):693-703. PubMed ID: 29035092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently.
    Beilfuss A; Sowa JP; Sydor S; Beste M; Bechmann LP; Schlattjan M; Syn WK; Wedemeyer I; Mathé Z; Jochum C; Gerken G; Gieseler RK; Canbay A
    Gut; 2015 May; 64(5):791-9. PubMed ID: 25134788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.